Replies to post #103598 on Biotech Values

[DewDiligence]

If this was true why did the FDA halt individual testing on IDX184 and IDX320?

IDIX didn’t—the FDA did.

As you stated the DDI study came up clean…

No—the DDI study (in healthy volunteers) is the one that encountered the problem.

IDX184 had previously shown unexplained tox signals at higher doses…

There were no safety signals of undue consequence when IDX184 was given as monotherapy or in combination with SoC.